Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-03-06 | Apellis Pharmaceuticals, Inc. | Watson David O.
(General Counsel) |
M | Common Stock | A | 3762 | $13.85 - $13.85 | $52,103 |
2024-01-29 | Apellis Pharmaceuticals, Inc. | Watson David O.
(General Counsel) |
S | Common Stock | D | 906 | $64.14 - $64.14 | $58,109 |
2024-01-22 | Apellis Pharmaceuticals, Inc. | Watson David O.
(General Counsel) |
S | Common Stock | D | 4184 | $65.00 - $65.00 | $271,943 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |